Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes
- 28 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 505, 113253
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infectionsClinical and Experimental Immunology, 2016
- IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 AntagonistsThe Journal of Immunology, 2016
- Light-sheet microscopy imaging of a whole cleared rat brain with Thy1-GFP transgeneScientific Reports, 2016
- Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal ModelsCancer Immunology Research, 2016
- Tumor-induced perturbations of cytokines and immune cell networksBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Fluorescent-labeled antibodies: Balancing functionality and degree of labelingAnalytical Biochemistry, 2010
- Immunity, Inflammation, and CancerCell, 2010
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T CellsJournal of Experimental Medicine, 2002
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996